MedPath

Telephone Administered Psychotherapy for the Treatment of Depression for Veterans in Rural Areas

Phase 1
Completed
Conditions
Beta-blocker Treatment
Heart Failure
Interventions
Behavioral: GTelephone-administered Cognitive-Behavioral Therapy (T-CBT)
Procedure: Provider education, computer reminders, nurse case management
Registration Number
NCT00012974
Lead Sponsor
US Department of Veterans Affairs
Brief Summary

The purpose of this study is to examine the efficacy of telephone-administered cognitive-behavioral therapy (T-CBT) in treating major depression among veterans served by community-based outpatient clinics (CBOCs) in the Veteran�s Integrated Service Network (VISN) 21, which serves rural areas in Northern California

Detailed Description

More that 20% of patients in primary care have depressive disorders. While primary care is the principal venue for treatment for depression, fewer than 25% of depressed patients receive adequate treatment for their depression. These outcomes can be worse when there are barriers to treatment such as living in a rural area. Several studies have found that given a choice, about two-thirds of depressed primary care patients prefer psychotherapy or counseling over antidepressant medication.

This is a controlled, randomized trial in which subjects meeting criteria for major depressive disorder (MDD) from primary care settings in VISN 21 including CBOCs will be randomly assigned to one of two conditions: 1) a 16-session manualized telephone administered cognitive behavioral therapy (T-CBT) delivered over 24 weeks or 2) a treatment-as-usual (TAU) condition. Telephone-administered cognitive behavioral therapy (T-CBT) is an intervention aimed at improving coping skills and social functioning. It is divided into two phases: 1) an initial treatment phase consisting of 12 weekly sessions aimed at reducing symptoms of depression, and 2) a booster phase in which 4 sessions are provided at increasingly greater intervals to target maintenance of treatment gains. T-CBT, administered by doctoral level psychologists, will be compared to a treatment-as-usual (TAU) condition that controls for the natural course of depression during the course of treatment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients must have chronic heart failure, systolic left ventricular dysfunction (ejection fraction less than or equal to 45%), not be receiving beta-blockers, and not have contraindications to beta-blockers.

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Arm 1Provider education, computer reminders, nurse case management-
Arm 1GTelephone-administered Cognitive-Behavioral Therapy (T-CBT)-
Primary Outcome Measures
NameTimeMethod
Reduction in severity of depression; scores on depression rating scales at baseline, 12 weeks and 24 weeks
Secondary Outcome Measures
NameTimeMethod
Maintenance of treatment gains at 6 month follow-up (week 48).

Trial Locations

Locations (2)

San Francisco VA Medical Center, San Francisco, CA

🇺🇸

San Francisco, California, United States

VA Northern California Health Care System, Mather, CA

🇺🇸

Sacramento, California, United States

© Copyright 2025. All Rights Reserved by MedPath